BEIJING, Dec. 20, 2013 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, announced it will attend the Sleep Disorders New Progress seminar in Qingdao on December 21, 2013. Professors from Beijing Tongren Hospital, Jiangsu People's Hospital, Beijing Peking Union Medical College Hospital and Shandong Qilu Hospital will attend this seminar, at which significant studies and scientific updates related to sleep apnea are expected to be presented. Dehaier will display and demonstrate the Sleep Respiratory Diagnosis System to the audiences.
Rayna Dong, Dehaier Marketing Director, said, "Our system can successfully treat most common sleep disorders. Our innovative, state-of-the-art system allows patients to diagnose the reasons for their sleep disorders so that they can seek appropriate care. The system also automatically captures raw data while patients sleep and monitors and analyzes such data to help select suitable CPAP devices for treatment and evaluation. Introduction of our new product at the Qingdao seminar will build a solid foundation for the next stage to fully enter the market. This seminar provides us a platform to communicate with industry leaders and stay abreast of industry developments. Our new System is one of our major strategic foci over the near term, and we expect it will play a major role in our growth in the long run."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, ten software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding potential results of attending the 2013 Qingdao Sleep Disorders New Progress Seminar. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.